US Patent Issued to ELECTROPHORETICS, KING'S COLLEGE LONDON on July 1 for "Biomarkers and methods relating to Alzheimer's disease" (British Inventors)

ALEXANDRIA, Va., July 3 -- United States Patent no. 12,345,717, issued on July 1, was assigned to ELECTROPHORETICS Ltd. (Surrey, Great Britain) and KING'S COLLEGE LONDON (London).

"Biomarkers and methods relating to Alzheimer's disease" was invented by Malcolm Andrew Ward (Surrey, Great Britain), Abdul Hye (London), Simon Harold Lovestone (London) and Richard James Butler Dobson (London).

According to the abstract* released by the U.S. Patent & Trademark Office: "Alzheimer's disease, the most common cause of dementia in older individuals, is a debilitating neurodegenerative disease for which there is currently no cure. In the past, AD could only be definitively diagnosed by brain biopsy or upon autopsy after a patient died. These methods,...